Stocks to sell

Insider buying, or the legal, reported purchase of shares in a company by its C-suite/board members/large shareholders, is considered a bullish signal. However, does that mean it is best to sell/avoid stocks insiders are selling? Put simply, it depends. Heavy insider selling, or even a lack of insider buying, can sometimes be a sign that those most
0 Comments
With the debt ceiling issue on the horizon, investors face the task of assessing their stock portfolios amidst government spending uncertainties. Given the prevailing uncertainty, investors should carefully consider specific stocks that may encounter significant challenges. Considering the looming uncertainties, this article highlights three stocks to sell. Investors are confronted with a complex decision-making process.
0 Comments
QuantumScape (NYSE:QS), a high-risk startup, aims to revolutionize the EV industry with its ambitious “forever battery” development, has become a polarizing stock to discuss. Some investors think that this is a company holding the “holy grail” of battery technology. However, many are impatient with the ongoing capital losses and uncertain timeline. Is it wise for
0 Comments
There’s no denying that electric vehicle manufacturer Lucid Group (NASDAQ:LCID) offers attractive and luxurious cars. It might tempt some financial traders to go on a bottom-fishing expedition with LCID stock. This doesn’t mean that these vehicles are strong sellers, though. The best policy is a cautious one, however, as Lucid Group’s EV delivery outlook is unclear.
0 Comments
Artificial intelligence has become one of the hottest stories of the decade, creating big opportunities for AI stocks. In fact, ever since the release of the AI chatbot ChatGPT, interest in the AI story has only gotten hotter, with top tech companies racing for a bigger piece of the AI pie. What makes the story
0 Comments
Biotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA:IBB) has fallen from a peak of $175 in 2021 to just $130 today. There are few signs of a biotech stock bubble at this point. That said, even with the sector at an overall discount, that’s not an
0 Comments
Identifying the worst-performing stocks in the current market can be challenging. Balancing long-term growth and short-term financial issues is daunting. We are entering a traditionally softer period for equities, particularly between May and October. Maybe this situation ought to prompt investors to consider stocks to sell now. Seasonal weakness plus economic headwinds could lead to
0 Comments
What does America’s central bank have to do with electric vehicle  battery technology company QuantumScape (NYSE:QS)? Actually, a lot. QS stock could continue to lose value this year because investors won’t keep throwing money at an unprofitable business. Sure, there was a time when companies with less-than-ideal financials attracted investors. Those days are probably in the
0 Comments